Displaying items 25-36 of 198
» View courant.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-17
•
Next >
-
West candidates Shumaker, Powers spar over jobs
Bristol Herald Courier, Va.While both candidates seeking the City Council's West District seat agree that economic development is key for the city's future, they differ on the best pathways. Incumbent David Shumaker and challenger Lea Powers are seeking the spot on the five-...Tags: Local Elections, Business, Entertainment, Music, Economic Policy
-
The Philadelphia Inquirer PhillyInc column
The Philadelphia InquirerYou never know when an acquisition involving the automobile industry in the Midwest in 1998 might affect a drug-development firm in the Philadelphia area in 2013. But that's apparently the backstory of $15 million in financing completed last week by...Tags: PhotoMedex Incorporated, Companies and Corporations, Corporate Officers, Johnson Controls Incorporated, Manufacturing and Engineering
-
REUTERS SUMMIT-Drug industry CEOs plotting more carve-outs
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * New generation of CEOs more open to restructuring * Established drug products in focus at Pfizer, GSK, Sanofi * Bankers see divestments helping to unlock...Tags: HIV, Restructuring and Recapitalization, Companies and Corporations, Corporate Officers, JPMorgan Chase & Co.
-
FACTBOX-Vaccine, drugs to fight new bird flu
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) May 6 (Reuters) - The U.N. World Health Organization and the U.S. Centers for Disease Control and Prevention are already working with samples of the new H7N9...Tags: Tamiflu (drug), Vaccines, Disease Prevention, Roche Holding AG, Wildlife
-
Big drugmakers think small with nanomedicine deals
Reuters* Nanomedicine promises greater precision and monitoring * Pfizer, Amgen, AstraZeneca among firms placing bets * Early-stage research but scientists see momentum building By Ben Hirschler LONDON, May 3 (Reuters) - Is nanomedicine the next big thing? A...Tags: Kaposi's sarcoma, Education, Medical Research, Amgen Inc., Science
-
Deals of the day -- mergers and acquisitions
ReutersMay 2 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** New York-based private equity firm Lightyear Capital has emerged as the lead bidder to buy SunTrust Banks Inc's RidgeWorth Investments...Tags: Norway, Archer Daniels Midland Incorporated, Real Estate Buyers, SunTrust Banks Incorporated, Interior Policy
-
JP Morgan, Greenhill advising GSK on sale of soft drinks brands
ReutersLONDON, May 2 (Reuters) - JP Morgan and Greenhill have been appointed to advise GlaxoSmithKline on the sale of its soft drinks brands Lucozade and Ribena, which analysts believe will fetch more than 1 billion pounds ($1.6 billion). A spokesman for...Tags: Deutsche Bank AG, Bain Capital, LLC, Japan, United Kingdom, Lion Capital Holdings
-
Gov. Pat McCrory picks lawyer as consumer advocate in utility cases
The News & ObserverGov. Pat McCrory on Monday named a Raleigh utility lawyer to represent the state's residents in utility rate hearings. He also named a state lawmaker and a public relations executive to the N.C. Utilities Commission, the state judicial panel that...Tags: Executive Branch, Raleigh, Merck & Company Incorporated, Crime, Law and Justice, The Home Depot
-
BRIEF-GSK,Theravance announce regulatory submission for Anoro Ellipta in Japan
ReutersLONDON, April 22 (Reuters) - GlaxoSmithKline Plc : * GSK and Theravance announce regulatory submission for Anoro Ellipta (UMEC/Vi) in Japan * Intends to commence global regulatory submissions for UMEC monotherapy later this yearTags: Theravance Incorporated, Japan
-
Athletes only too happy to be 'lab rats'
After discovering that a promising new drug caused multiple types of cancer in lab animals, the pharmaceutical company GlaxoSmithKline stopped developing the compound. But the failed experimental drug, called GW501516, is making a comeback in another...
Tags: Medical Research, Steroids, Newspaper and Magazine, Science, Crime, Law and Justice
-
PRESS DIGEST - SUNDAY BRITISH BUSINESS - APRIL 21
ReutersLONDON, April 21 (Reuters) - British newspapers reported the following business stories on Sunday: The Sunday Times: MPs REVIVE PLAN FOR 'BAD BANK' Senior MPs have demanded that the Treasury investigates a break-up of British state-backed banks Lloyds...Tags: Verizon Wireless, London Heathrow Airport, Corporate Officers, United Kingdom, Economy, Business and Finance
-
FDA raises safety concerns on Valeant's seizure drug
ReutersApril 26 (Reuters) - The U.S. Food and Drug Administration said the an anti-seizure drug developed by Valeant Pharmaceuticals Inc and co-marketed with GlaxoSmithKline Plc may cause eye and skin problems. The U.S. health regulator warned that the drug,...Tags: European Union, Thomson Corporation, Seizures, Food and Drug Administration
Apr 27, 2013
|Story| McClatchy-Tribune
May 8, 2013
|Story| McClatchy-Tribune
May 7, 2013
|Story| Reuters
May 6, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
May 2, 2013
|Story| Reuters
May 2, 2013
|Story| Reuters
Apr 30, 2013
|Story| McClatchy-Tribune
Apr 22, 2013
|Story| Reuters
Apr 21, 2013
|Story| Chicago Tribune
Apr 21, 2013
|Story| Reuters
Apr 26, 2013
|Story| Reuters
Original site for GlaxoSmithKline PLC topic gallery.
